NATIONAL TRENDS IN GASTROESOPHAGEAL REFLUX SURGERY

Similar documents
Physiotherapists in Canada, 2011 National and Jurisdictional Highlights

Role of laparoscopic antireflux surgery in the management of chronic GERD symptoms

Corneal transplant (CT) surgery remains the most common

General Anesthesia Gender patterns amongst Canadian anesthesiologists

Results of a national needs. assessment for continuing medical education of family

Antimicrobial Resistant Organisms (ARO) Surveillance SURVEILLANCE REPORT FOR DATA FROM JANUARY TO DECEMBER

Several recent studies have documented

Report from the National Diabetes Surveillance System:

= 0.002) 117 #!. 12, : = 0.45; P

Bariatric Surgery in Canada

The Projection of Prevalence and Cost of Diabetes in Canada: 2000 to 2016

4/24/2015. History of Reflux Surgery. Recent Innovations in the Surgical Treatment of Reflux

CCORT ATLAS PAPER Cardiac procedures after an acute myocardial infarction across nine Canadian provinces

Canadian Society for Vascular Surgery Société canadienne de chirurgie vasculaire

CCORT ATLAS PAPER. Outcomes of acute myocardial infarction in Canada

Estimating the volume of Contraband Sales of Tobacco in Canada

Appendix B Fracture incidence and costs by province

Geriatric Medicine. Geriatric Medicine Profile

Use of laparoscopy in general surgical operations at academic centers

Provincial Projections of Arthritis or Rheumatism, Special Report to the Canadian Rheumatology Association

Endoscopic vs Surgical Therapies for GERD: Is it Time to Put down the Scalpel?

Critical Care Medicine. Critical Care Medicine Profile

It is well established that there are

Neurology. Neurology Profile

General Internal Medicine. General Internal Medicine Profile

The diagnosis of gastroesophageal reflux disease (GERD)

FKT4. Richard Fleet, MD, PhD, CCMF(MU)

COMPUS OPTIMAL THERAPY REPORT. Supporting Informed Decisions. À l appui des décisions éclairées

Poison Control Centres

December 3 to 9, 2017 (Week 49)

Respirology manpower in Canada A report for the Canadian Thoracic Society Education Committee

PROFILE AND PROJECTION OF DRUG OFFENCES IN CANADA. By Kwing Hung, Ph.D. Nathalie L. Quann, M.A.

Mental Health Statistics, to

November 5 to 11, 2017 (Week 45)

What is the distribution of deaths due to cerebrovascular disease in Ontario?

Archived Content. Contenu archivé

Mexico. Figure 1: Confirmed cases of A[H1N1] by date of onset of symptoms; Mexico, 11/07/2009 (Source: MoH)

OTOLARYNGOLOGY PROFILE

Waiting Your Turn. Wait Times for Health Care in Canada, 2018 Report. by Bacchus Barua and David Jacques. with Antonia Collyer

Surgical Outcomes: A synopsis & commentary on the Cardiac Care Quality Indicators Report. May 2018

GERIATRIC MEDICINE PROFILE

Physical Medicine & Rehabilitation. Physical Medicine and Rehabilitation Profile

Health Canada. Santé Canada. Tuberculosis in Canada pre-release

OxyContin in the 90 days prior to it being discontinued.

Health Interventions in Ambulatory Cancer Care Centres DRAFT. Objectives. Methods

West Nile virus and Other Mosquito borne Diseases National Surveillance Report English Edition

CHAPTER 4: Population-level interventions

A jurisdictional review of the legislation governing informed consent by chiropractors across Canada

Trends in adult obesity

vaccination in Canada Bernard Duval, md, mph, frcpc Institut National de Santé Publique du Québec Québec, Canada Sevilla,

ISSN East Cent. Afr. J. surg

Surgical treatment for gastroesophageal reflux GENERAL THORACIC SURGERY

Macrolides in community-acquired pneumonia and otitis media Canadian Coordinating Office for Health Technology Assessment

The 2012 SAGE Wait Time Program: Survey of Access to GastroEnterology in Canada Can J Gastroenterol 2013;27:83-9.

Research. Is Canadian women s breast cancer screening behaviour associated with having a family doctor? Web exclusive Research

Education Performance on ABA- ASA In-training Examination predicts success for RCPSC certification

Waiting Your Turn Wait Times for Health Care in Canada, 2017 Report

DERMATOLOGY PROFILE GENERAL INFORMATION

LIST OF FIGURES INTRODUCTION

Aussi disponible en français sous le titre : Le Diabète au Canada : Rapport du Système national de surveillance du diabète, 2009

Suicide in the Canadian Forces 1995 to 2012

HEALTHCARE- ASSOCIATED CLOSTRIDIUM DIFFICILE INFECTIONS IN CANADIAN ACUTE- CARE HOSPITALS

TUBERCULOSIS IN CANADA 2010 PRE-RELEASE

There is increasing concern over the presence and availability

Cervical Cancer and Pap Test Utilisation in Manitoba

PSYCHOLOGIST SALARY COMPARISON October 2016

Addiction Treatment in Canada: The National Treatment Indicators Report

original article Long-term management of patients with celiac disease: Current practices of gastroenterologists in Canada

Demand for Ocular Tissue in Canada - Final Report

COLLABORATIVE STAGE TRAINING IN CANADA

Health Canada Endorsed Important Safety Information on Infanrix Hexa

Varicella is one of the most common human infections; nearly

Canadian Organ Replacement Register Annual Report: Treatment of End-Stage Organ Failure in Canada, 2003 to 2012

VACCINE COVERAGE IN CANADIAN CHILDREN

VISION PROBLEMS AMONG SENIORS Wayne J. Millar

West Nile Virus and Other Mosquito-borne Diseases National Surveillance Report English Edition September 11 to September 17, 2016 (Week 37)

West Nile Virus and Other Mosquito-borne Diseases National Surveillance Report English Edition September 18 to September 24, 2016 (Week 38)

MEDICAL POLICY SUBJECT: MAGNETIC ESOPHAGEAL RING/ MAGNETIC SPHINCTER AUGMENTATION FOR THE TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE (GERD)

November 9 to 15, 2014 (week 46)

Informing a research agenda for the Canadian chiropractic profession

12 to 18 January, 2014 (Week 03)

ICD-10 Reciprocal Billing File Technical Specifications Reference Guide for Ontario Hospitals

April 8 to April 14, 2012 (Week 15)

original article Operative trends and physician treatment costs associated with Dupuytren s disease in Canada

Recent Changes in Cervical Cancer Screening in Canada

Original Article Article original

ORIGINAL ARTICLE. Laparoscopic Antireflux Surgery in the Treatment of Gastroesophageal Reflux in Patients With Barrett Esophagus

Health Interventions in Ambulatory Cancer Care Centres

ENDOCRINOLOGY/METABOLISM PROFILE

National Treatment Indicators Report

MAJOR RELEASES OTHER RELEASES PUBLICATIONS RELEASED 5

2017 JOB MARKET & EMPLOYMENT SURVEY EXECUTIVE SUMMARY

Occupational Noise Exposure

Impaired driving statistics

CADTH Optimal Use Report

Mina Tadrous, Diana Martins, Zhan Yao, Kimberly Fernandes, Samantha Singh, Nikita Arora, David Juurlink, Muhammad Mamdani and Tara Gomes

Canadian Organ Replacement Register Annual Report. Treatment of End-Stage Organ Failure in Canada, 2000 to 2009

COMPUS OPTIMAL THERAPY REPORT. Supporting Informed Decisions. À l appui des décisions éclairées

Industry Retail Programs : The Tobacco Industry s Price Segmentation Tool. Flory Doucas. Quebec Coalition for Tobacco Control November 28 th, 2017

Transcription:

Original Article Article original NATIONAL TRENDS IN GASTROESOPHAGEAL REFLUX SURGERY Ross L. McMahon, MD; C. Dale Mercer, MD OBJECTIVES: To assess the surgical technique and the frequency of different types of antireflux surgery used in Canada after the introduction of laparoscopic antireflux surgery. DESIGN: Gastroesophageal reflux (GER) surgery and population data in fiscal years 1992 through 1996. were accessed through the Canadian Institute of Health Information, provincial health ministries, MED ECHO and Statistics Canada databases. Data were also analysed by province and nationally for type of surgery (e.g., open abdominal, thoracic, thoracoscopic and laparoscopic). RESULTS: National data showed a slight increase in GER surgery in the last 5 years. Laparoscopic surgery increased 2.8 fold in 1993 and 1.6 fold in 1995 over the previous years. Open abdominal cases decreased 1.1 fold from 1992 to 1996. Thoracic cases remained essentially unchanged. Provincial and regional disparities in procedures per 100 000 population exist (Ontario 7.1 versus Nova Scotia 20.7). Areas in which little or no laparoscopic surgery was done had an average increase of 3%, whereas areas in which laparoscopic surgery was done had an average increase of 16% in GER surgery during the course of the study. In provinces west of Quebec (with the exception of Manitoba) more than 50% of GER surgery is laparoscopic; in areas east of Ontario less than 25% of GER surgery is performed laparoscopically. Five provinces (Manitoba, Quebec, Nova Scotia, Prince Edward Island and Newfoundland) performed significantly fewer laparoscopic procedures than the national average. CONCLUSIONS: The frequency of GER surgery is increasing modestly in Canada and is performed most often by the open abdominal route. Regional disparities in open and laparoscopic techniques are apparent. Laparoscopic surgery for GER is increasing rapidly and accounts for the decrease in open GER surgery. OBJECTIFS : Le Canada après l'apparition du montage chirurgical antireflux par laparoscopie CONCEPTION : On a consulté les bases de données de l'institut canadien d'information sur la santé, des ministères provinciaux de la santé, de MED ECHO et de Statistique Canada afin d'obtenir, pour les exercices 1992 à 1996, les données sur la population et les montages chirurgicaux effectués à la suite d'un reflux gastro-œsophagien (RGO). On a aussi analysé les données provinciales et nationales sur le type d'intervention (p. ex., à abdomen ouvert, thoracique, thoracoscopique et laparoscopique). RÉSULTATS : Les données nationales indiquent une légère augmentation du nombre d'interventions chirur - gicales de traitement du RGO au cours des cinq dernières années. Les interventions par laparoscopie ont été 2,8 fois plus nombreuses en 1993 et 1,6 fois plus nombreuses en 1995 par rapport aux années précédentes. Les interventions à abdomen ouvert ont été 1,1 fois moins nombreuses entre 1992 et 1996. La situation est demeurée à peu près inchangée dans le cas des interventions thoraciques. Le nombre d'interventions exécutées par 100 000 habitants varie selon les provinces et les régions (7,1 en Ontario contre 20,7 en Nouvelle- Écosse). Dans les régions où cette intervention n'existait à peu près pas, le traitement chirurgical du RGO par laparoscopie a affiché une augmentation moyenne de 3 %, tandis qu'on a constaté au cours de l'étude, dans les régions où la procédure était déjà employée, une hausse moyenne de 16 %. Dans les provinces à l'ouest du Québec (à l'exception du Manitoba), plus de 50 % des chirurgies de traitement du RGO ont été faites par laparoscopie, tandis dans les régions à l'est de l'ontario, moins de 25 % de ces interventions ont eu lieu par laparoscopie. Cinq provinces (Manitoba, Québec, Nouvelle-Écosse, Île-du-Prince-Édouard et Terre-Neuve) ont exécuté beaucoup moins d'interventions laparoscopiques par rapport à la moyenne nationale. From the Department of Surgery, Division of General Surgery, Queen s University, Kingston, Ont. Presented in part at the annual meeting of the Royal College of Physicians and Surgeons of Canada, Montreal,Que., September 1996 and at the Canadian Association of General Surgeons Resident Research Retreat, Mississauga, Ont., June 1996. Accepted for publication June 14, 1999. Correspondence to: Dr. C. Dale Mercer, Division Chair, Division of General Surgery, Hotel Dieu Hospital, 166 Brock St., Kingston, ON K7L 5G2; fax 613 546-4854, cdm@post.queensu.ca 2000 Canadian Medical Association (text and abstract/résumé) 48 JCC, Vol. 43, N o 1, février 2000

GASTROESOPHAGEAL REFLUX SURGERY IN CANADA CONCLUSIONS : La fréquence des chirurgies de traitement du RGO augmente faiblement au Canada, et les interventions sont exécutées la plupart du temps par voie abdominale. Les disparités régionales au niveau des interventions abdominales et laparoscopiques sont évidentes. La fréquence du traitement chirurgical du RGO par laparoscopie augmente rapidement, ce qui explique la diminution des interventions ouvertes. Gastroesophageal reflux disease (GERD) is endemic in Canada. Up to 40% of adults have symptoms. The key to treatment is effective maintenance therapy with proton pump inhibitors. The other alternative is antireflux surgery. Studies have shown that surgery for GERD is effective, and cost-effectiveness studies have confirmed its benefit in younger patients. 1,2 Since the introduction of laparoscopic cholecystectomy, surgeons and patients attitudes toward biliary tract surgery have changed dramatically. In fact, the change in the overall provision of health care related to the diagnosis of cholelithiasis and its related diseases is based solely on the laparoscopic approach. 3 Studies have demonstrated the benefit of laparoscopic biliary tract surgery with respect to pain, length of hospital stay and time to full recovery. 4 6 Randomized controlled trials of laparoscopic cholecystectomy compared with open cholecystectomy have shown the superiority of the laparoscopic technique. 7 However, after widespread adoption of this procedure, complications unique to the laparoscopic technique began to appear. 8 11 Also, known complications of open cholecystectomy (e.g., bile-duct injuries) were reported with increased frequency after use of the laparoscopic technique. 8,9 These findings have spawned a new series of papers in the literature on prevention and management of these complications. 9,10 With the public s increased awareness of health care issues and technologic advances it was not surprising that patient demand, in part, led to the explosion of laparoscopic cholecystectomy before adequate controlled clinical trials were performed. The laparoscopic era for gastrointestinal surgery also led to changes in health care delivery, placing greater emphasis on ambulatory or short-stay surgery. Some authors have questioned the value of the laparoscopic antireflux surgical technique. 12 If laparoscopic antireflux surgery is seen as an effective alternative to lifelong medication, it must be be based on sound rationale and be performed on the right patients as determined by clinical criteria and objective diagnostic tests. The first report of a laparoscopic Nissen fundoplication was in 1991. 13 Since then, reports of laparoscopic Nissen fundoplication and laparoscopic Hill repair have appeared. 14,15 Outcome studies looking at physiologic assessment, symptoms and quality of life measures have shown good results in 93% to 96% of patients having typical symptoms of GERD. 16 18 To answer the question: Is antireflux surgery increasing or decreasing in Canada and to what extent has this been influenced by the advent of laparoscopic surgery? we searched the Canadian health databases. METHODS The Canadian Institute for Health Information (CIHI), provincial health ministries and MED ECHO databases were accessed for antireflux surgery data during fiscal years 1992/93, 1993/94, 1994/95 and 1995/96. The data were provided by geographic area, provincially and nationally, and included the numbers of antireflux procedures listed by operative approach (e.g., laparoscopic, open abdominal, thoracoscopic, and thoracic) but not the specific technique used (i.e., Nissen, Hill or Belsey procedure). When CIHI information was incomplete, the health ministry of that province was contacted to obtain the missing data. The data for Quebec were completely supplied by the Quebec Ministry of Health through the MED ECHO database. Statistics Canada provided national, provincial and municipal population data. A municipal database was created but does not take into account the population of the referral area for individual cities, making the rate per 100 000 population of questionable significance. The data were analysed using Lotus 123 97 and Approach 97. RESULTS The number of antireflux procedures performed in each province is shown in Table I. Thoracoscopic antireflux surgery is not performed commonly in Canada. The data are presented graphically for the fiscal year 1996 in Table II. It is evident that provincial disparities exist in the use of antireflux surgery. The rate of antireflux surgery in 1996 per 100 000 population for all of Canada was 11.4. Prince Edward Island had the lowest rate at 3.0, and Nova Scotia had the highest rate at 19.6. Disparities also exist in the use of laparoscopic antireflux surgery (LS). The rate of LS is highest in Alberta and the western provinces with the exception of Manitoba and, with the exception of New Brunswick, is performed minimally east of Ontario and in the 2 territories. There has been a marked increase in the utilization of laparoscopic GER surgery (Fig. 1). Between 1992 and 1996, those regions using LS at or above the national average had an overall 16% increase in GER surgery. This compares with a 3% increase in the use of antireflux surgery in those provinces where LS is not prominent and with a 3.5% decrease in the overall national use of antireflux surgery. In those regions where essentially no la- CJS, Vol. 43, No. 1, February 2000 49

MCMAHON AND MERCER Table I National Date of Antireflux Procedures Performed Between Fiscal Years 1992 and 1996 Fiscal year 1992 1993 1994 1995 1996 Province/population* No. Rate No. Rate No. Rate No. Rate No. Rate British Columbia/3.5 266 7.6 283 8.1 274 7.8 382 8.1 445 12.7 Alberta/2.6 446 17.0 401 15.3 438 16.7 480 18.3 448 17.1 Saskatchewan/ 0.9 87 8.8 119 12.0 118 11.9 104 10.5 122 12.3 Manitoba/1.1 75 6.8 91 8.3 104 9.4 82 7.4 92 8.3 Ontario/10.4 1016 9.8 1137 10.9 1076 10.3 1208 11.6 1144 11.0 Quebec/7.0 553 7.9 598 8.5 597 8.5 597 8.5 609 8.7 New Brunswick/0.7 90 12.3 95 13.0 79 10.8 110 15.0 110 15.0 Nova Scotia/0.9 121 23.4 224 24.8 189 20.9 218 24.1 177 19.6 Prince Edward Island/0.1 5 3.8 2 1.5 6 4.5 11 8.3 4 3.0 Newfoundland/0.6 62 11.1 48 8.6 63 11.2 78 13.9 53 9.4 Yukon/Northwest Territories/0.1 7 7.8 8 8.9 4 4.4 3 3.3 7 7.8 Canada/28.1 2819 10.0 3006 10.7 2948 10.5 3273 11.7 3211 11.4 10 6 Rate per 100 000 population Table II National and Provincial Antireflux Surgery Rates for the Fiscal Year 1996* Type of surgery Province Abdominal Thoracic Laparoscopic British Columbia 6.5 1.0 5.2 Alberta 10.3 0.6 6.3 Saskatchewan 5.8 0.6 6.0 Manitoba 7.4 0.9 0 Ontario 6.2 1.1 3.7 Quebec 7.5 0.6 0.5 New Brunswick 10.5 0.8 3.7 Nova Scotia 18.4 1.0 0.1 Prince Edward Island 2.3 0.8 0 Newfoundland 7.9 1.1 0.5 Yukon/Northwest Territories 6.6 1.1 0 Canada 7.5 0.9 3.0 *Procedures per 100 000 population paroscopic surgery was performed in 1996, there was a net decrease of 6.5% in their overall antireflux surgery rates between 1992 and 1996. Five regions that performed 2 or fewer laparoscopic repairs per year in fiscal year 1993 (Manitoba, Quebec, Nova Scotia, Prince Edward Island and Newfoundland) stopped performing laparoscopic surgery thereafter. Thirteen regions started performing laparoscopic antireflux surgery after fiscal year 1993. DISCUSSION Concerns exist among many esophageal surgeons that the rigid indications for GER surgery may be relaxed and that inappropriate antireflux surgery will be performed simply because it can be done laparoscopically. 19 Because of the increasing interest in laparoscopic surgery, a concern for patient welfare, and the availability of laparoscopic fundoplication, the number of patients referred for laparoscopic GER surgery is likely to increase, so the concerns may be valid. Such findings have been reported for laparoscopic cholecystectomy. 20 Laparoscopic antireflux surgery is one of a number of advanced laparoscopic techniques now becoming more readily available. Although the learning curve for mastery of the GER technique is much longer than for cholecystectomy, surgeons may believe that it is simply a natural extension to their skills acquired in biliary tract surgery. This belief combined with the perceived benign nature of laparoscopic procedures could lead to a 50 JCC, Vol. 43, N o 1, février 2000

GASTROESOPHAGEAL REFLUX SURGERY IN CANADA proliferation of this operation by surgeons not skilled in analysing patients with suspected GERD. However, as shown in our study, laparoscopic surgery has not yet resulted in a marked proliferation of the number of antireflux procedures. We found that the use of antireflux surgery to control the symptoms of GERD varies widely from one geographic area to another. This finding could be explained in part by the referral patterns of the gastroenterologists and family doctors. The data also support a national trend toward increasing use of laparoscopic antireflux surgery with a consequent reduction in open abdominal techniques. It is of concern that in some regions using laparoscopic surgery only a few such procedures are performed each year. This study could not identify if these procedures were performed by a single surgeon or by several surgeons. Any future outcome studies for GER surgery must evaluate what objective investigations are FIG. 1. National antireflux surgery rates by year. utilized preoperatively in regions where antireflux surgery is done. Laparoscopic techniques are still evolving, so outcome studies will need to evaluate these changes for established laparoscopic esophageal surgeons also. CONCLUSIONS The future of laparoscopic antireflux surgery and its place in the management of GERD is still unclear, but it appears that Canadian surgeons are adopting the laparoscopic approach in place of the open approach. We conclude that, unlike the situation after the introduction of laparoscopic cholecystectomy, the introduction of laparoscopic antireflux procedures has not yet resulted in an increase in GER surgery, which is still performed most often by the open abdominal route. Marked regional disparities in open and laparoscopic surgery are apparent. Although this study did not look at the reasons behind such differences, we conclude that since this type of surgery is performed on patients who have usually been evaluated by gastroenterologists, practice referral patterns could account for the disparities. Laparoscopic surgery is infrequent but is increasing rapidly, and the increase in laparoscopic GER surgery has been coincident with a decrease in open GER surgery. The number of centres offering laparoscopic GER surgery is also increasing. References 1. Spechlar S. Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. N Engl J Med 1992;326:786-92. 2. Coley CM, Barry M, Spechlar SJ, Williford WO, Mulley AG. Initial medical vs. surgical therapy for complicated or chronic gastroesophageal reflux disease (GERD): a cost effectiveness analysis [abstract]. Gastroenterology 1993; 104(4):A. 3. Soper NJ, Stockmann PT, Dunnegan DL, Ashley SW. Laparoscopic cholecystectomy. gold standard? Arch Surg 1992;127:917-21. 4. McMahon AJ, Russell IT, Ramsay G, Sunderland G, Baxter JN, Anderson JR, et al. Laparoscopic and minilaparotomy cholecystectomy: a randomized trial comparing postoperative pain and pulmonary function. Surgery 1994; 115 (5):533-9. 5. Smith R, Pace RF. Outpatient laparoscopic cholecystectomy [abstract]. Can J Surg 1992;35(4):442. 6. Arregui ME, Davis CJ, Arkush A, Nagan RF. In selected patients outpatient laparoscopic cholecystectomy is safe and significantly reduces hospitalization charges. Surg Laparosc Endosc 1991; 4:240-5. 7. Barkun JS, Barkun AN, Sampalis JS, Fried G, Taylor B, Wexler MJ, et al. Randomised controlled trial of laparoscopic versus mini cholecystectomy. The McGill Gallstone Treatment CJS, Vol. 43, No. 1, February 2000 51

MCMAHON AND MERCER Group. Lancet 1992;340(8828): 1116-9. 8. Kern KA. Medicolegal analysis of bile duct injury during open cholecystectomy and abdominal surgery. Am J Surg 1994;168:217-22. 9. Woods MS, Traverso LW, Kozarek RA, Tsao J, Rossi RL, Gough D, et al. Characteristics of biliary tract complications during laparoscopic cholecystectomy: a multi-institutional study. Am J Surg 1994;167(1):27-34. 10. Vitale GC, Stephens G, Wieman TJ, Larson GM. Use of endoscopic retrograde cholangiopancreatography in the management of biliary complications afer laparoscopic cholecystectomy. Surgery 1993;114(4):806-14. 11. Cappuccino H, Cargill S, Bguyen T. Laparoscopic cholecystectomy; 563 cases at a community teaching hospital and a review of 12,201 cases in the literature. Surg Laparosc Endosc 1994; 4(3):213-22. 12. Collard JM, Gheldere CA, DeKock M, Otte JB, Kestens PJ. Laparoscopic antireflux surgery. What is real progress? Ann Surg 1994:220(2):146-54. 13. Dellemagne B. Laparoscopic Nissen fundoplication: preliminary report. Surg Laparosc Endosc 1991;1:138-43. 14. Kraemer SJ, Aye R, Kozarek RA, Hill LD. Laparoscopic Hill repair. Gastrointest Endosc 1994;40(2):155-9. 15. Swanstrom L, Wayne R. Spectrum of gastrointestinal symptoms after laparoscopic fundoplication. Am J Surg 1994; 167:538-41. 16. Hunter JG, Trus TL, Branum GD, Waring JP, Wood WC. A physiologic approach to laparoscopic fundoplication for gastroesophageal reflux disease. Ann Surg 1996;223(6):673-87. 17. Peters JH, DeMeester TR, Crookes P, Oberg S, de Vos Shoop M, Hagen JA, Bremner CG. The treatment of gastroesophageal reflux disease with laparoscopic Nissen fundoplication. Prospective evaluation of 100 patients with typical symptoms. Ann Surg 1998;228(1):40-50. 18. So JB, Zeitels SM, Rattner DW. Outcomes of atypical symptoms attributed to gastroesophageal reflux treated by laparoscopic fundoplication. Surgery 1998;124(1):28-32. 19. Jamieson GG, Watson DI, Britten- Jones R, Mitchell PC, Anvari M. Laparoscopic Nissen fundoplication. Ann Surg 1994;220(2):137-45. 20. Legorreta AP, Silber JH, Costantino GN, Kobylinski RW, Zatz SL. In creased cholecystectomy rate after the introduction of laparoscopic cholecystectomy. JAMA 1993;270(12):1429-32. 52 JCC, Vol. 43, N o 1, février 2000